These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6298176)

  • 1. Ceftriaxone therapy of group B streptococcal bacteraemia and meningitis in infant rats.
    Delaplane D; Yogev R; Shulman ST
    J Antimicrob Chemother; 1983 Jan; 11(1):69-73. PubMed ID: 6298176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of cefmenoxime in experimental group B streptococcal bacteraemia and meningitis.
    Kim KS
    J Antimicrob Chemother; 1986 Feb; 17(2):239-44. PubMed ID: 3516964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of imipenem in experimental group B streptococcal bacteremia and meningitis.
    Kim KS
    Chemotherapy; 1985; 31(4):304-9. PubMed ID: 3896683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococci.
    Kim KS; Bayer AS
    Antimicrob Agents Chemother; 1985 Jul; 28(1):51-4. PubMed ID: 3899006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antimicrobial therapy for experimental infections due to group B Streptococcus on mortality and clearance of bacteria.
    Kim KS
    J Infect Dis; 1987 Jun; 155(6):1233-41. PubMed ID: 3553349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of teicoplanin in experimental group B streptococcal bacteremia and meningitis.
    Kim KS; Hang JH; Bayer AS
    Chemotherapy; 1987; 33(3):177-82. PubMed ID: 2954777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seven days of ceftriaxone therapy is as effective as ten days' treatment for bacterial meningitis.
    Lin TY; Chrane DF; Nelson JD; McCracken GH
    JAMA; 1985 Jun; 253(24):3559-63. PubMed ID: 3889396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New concepts in the management of infants and children with meningitis.
    McCracken GH
    Pediatr Infect Dis; 1983; 2(3 Suppl):S51-5. PubMed ID: 6306611
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of cefotaxime and latamoxef for Escherichia coli bacteremia and meningitis in newborn rats.
    Kim KS; Manocchio M; Bayer AS
    Chemotherapy; 1984; 30(4):262-9. PubMed ID: 6086247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis.
    Scheld WM; Rocha H; Sande MA; Bryan JP
    Am J Med; 1984 Oct; 77(4C):42-9. PubMed ID: 6093518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of cefotaxime and ceftriaxone alone and in combination with penicillin, ampicillin and piperacillin against neonatal meningitis pathogens.
    Hoogkamp-Korstanje JA
    J Antimicrob Chemother; 1985 Sep; 16(3):327-34. PubMed ID: 3932295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro activity of moxifloxacin (8-methoxyquinolone) alone or in combination with cefotaxime against group B streptococci].
    Jacquier H; Cruaud P; Poilane I; Lachassinne E; Gaudelus J; Collignon A
    Pathol Biol (Paris); 2007 Nov; 55(8-9):412-7. PubMed ID: 17905539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftriaxone therapy of meningitis and serious infections.
    Steele RW
    Am J Med; 1984 Oct; 77(4C):50-3. PubMed ID: 6093519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis.
    Del Rio M; McCracken GH; Nelson JD; Chrane D; Shelton S
    Antimicrob Agents Chemother; 1982 Oct; 22(4):622-7. PubMed ID: 6295262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility to six antibiotics of group B streptococci isolated from cerebrospinal fluid.
    Mulder C; Bol P; Nabbe A; Zanen B
    Scand J Infect Dis; 1985; 17(2):191-3. PubMed ID: 3895400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An analysis of 181 cases with blood stream infection caused by Streptococcus agalactiae in children from 2011 to 2015: a multi-center retrospective study].
    Hua CZ; Yu H; Zhuang JQ; Li XL; Xu HM; Luo QE; Lu HP; Yu HM; Cao Y; Chen YP; Zhang T; Jing CM; Du LZ; Wang CQ; Lin ZL; Zhang H; Chen XJ; Hua ZY
    Zhonghua Er Ke Za Zhi; 2016 Aug; 54(8):577-81. PubMed ID: 27510868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ceftriaxone in neonates and infants with meningitis.
    Martin E; Koup JR; Paravicini U; Stoeckel K
    J Pediatr; 1984 Sep; 105(3):475-81. PubMed ID: 6088747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quantitative study of the antibacterial effect of cefotaxime and ceftriaxone during experimental Escherichia coli K1 bacteremia in chickens].
    Labarthe JC; Guillot JF; Mouline C; Bree A
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):664-7. PubMed ID: 2677929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of penicillin to eradicate the carrier state of group B Streptococcus in infants.
    Paredes A; Wong P; Yow MD
    J Pediatr; 1976 Aug; 89(2):191-3. PubMed ID: 781199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of group B streptococcal infection.
    Truog WE; Davis RF; Ray CG
    J Pediatr; 1976 Aug; 89(2):185-6. PubMed ID: 781196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.